Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

McKesson Takes VA Contract From Amerisource, Cites Technology As Reason

  • News

Executive Summary

McKesson's automated ordering technology is one reason the wholesaler won the Veterans Affairs prime vendor contract from the incumbent AmerisourceBergen, McKesson said Dec. 31

You may also be interested in...



McKesson Takes Over VA Contract From AmerisourceBergen May 10

AmerisourceBergen will serve the Department of Veterans Affairs pharmaceutical prime vendor contract through May 9 at a fee of cost minus 5%

McKesson Takes Over VA Contract From AmerisourceBergen May 10

AmerisourceBergen will serve the Department of Veterans Affairs pharmaceutical prime vendor contract through May 9 at a fee of cost minus 5%

VA Wholesaler Dispute: McKesson And ABC Head To Court In March

Arguments in the March 11 court hearing on the Department of Veterans Affairs' wholesaler contract may focus on how the department assessed the savings from the bids it received

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director

Puberty Blockers: FDA's Califf Asked If REMS, Boxed Warning Against Off-Label Use In The Works

ADHD Drugs: FDA Commissioner Blames Inappropriate Prescribing For Shortages

Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug

See All
UsernamePublicRestriction

Register

PS043098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By